How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Microsoft announced the Azure Functions serverless agents runtime in public preview at Build 2026, turning the event-driven compute service into a platform for building and hosting AI agents. The ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

Protein function predictions are bioinformatic methods (i.e. involving computation using software) that aim to predict the function of a protein. Protein function analyses use protein sequences and ...

Virtual private server (VPS) hosting is an excellent combination of affordability and power. The top VPS web hosting services we've tested let you build an attractive, stable, and secure website with ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...